The predictive role of circulating microparticles in patients with chronic heart failure
The study aim was to evaluate whether circulating microparticles with apoptotic or non-apoptotic phenotypes are useful for risk assessment of 3-year cumulative fatal and non-fatal cardiovascular events in CHF patients. The incidence of fatal and non-fatal cardiovascular events, as well as the freque...
Saved in:
| Published in | BBA clinical Vol. 3; pp. 18 - 24 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Netherlands
Elsevier
01.06.2015
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The study aim was to evaluate whether circulating microparticles with apoptotic or non-apoptotic phenotypes are useful for risk assessment of 3-year cumulative fatal and non-fatal cardiovascular events in CHF patients.
The incidence of fatal and non-fatal cardiovascular events, as well as the frequency of occurrence of death from any cause in a cohort of 388 patients with CHF during 3 years of observation was studied prospectively. Circulating levels of NT-pro brain natriuretic peptide (NT-pro-BNP), high-sensitivity C-reactive protein (hs-CRP), and endothelial apoptotic microparticles (EMPs) were measured at baseline.
Median follow-up was 2.32 years (IQR = 1.8-3.1). During follow-up, 110 cardiovascular events (including 43 fatal cases) were determined. Additionally, 74 subjects were hospitalized repetitively due to worsening CHF and also 16 subjects were readmitted in the hospital due to other cardiovascular reasons. In the univariate logistic regression analysis, the main factors independently related with cumulative endpoints were creatinine, fasting glucose, HbA1c, total cholesterol, uric acid, various types of EPMs, NT-pro-BNP, hs-CRP, NYHA class, decreased left ventricular ejection fraction (LVEF) less 45%, and type 2 diabetes mellitus. In multivariate model NYHA class, decreased LVEF (less 45%), NT-pro-BNP, hs-CRP, CD144 +/CD31 +/annexin V + EMPs, and CD31 +/annexin V + EMPs remained statistically significant for cumulative endpoint. Adding of CD144 +/CD31 +/annexin V + EMCs and CD31 +/annexin V + EMCs to the standard ABC model may improve the relative IDI for cumulative endpoint by 11.4% and 10.5% respectively.
Apoptotic phenotype of circulating microparticles may relate 3-year combined clinical outcomes in CHF patients. |
|---|---|
| AbstractList | The study aim was to evaluate whether circulating microparticles with apoptotic or non-apoptotic phenotypes are useful for risk assessment of 3-year cumulative fatal and non-fatal cardiovascular events in CHF patients.
The incidence of fatal and non-fatal cardiovascular events, as well as the frequency of occurrence of death from any cause in a cohort of 388 patients with CHF during 3 years of observation was studied prospectively. Circulating levels of NT-pro brain natriuretic peptide (NT-pro-BNP), high-sensitivity C-reactive protein (hs-CRP), and endothelial apoptotic microparticles (EMPs) were measured at baseline.
Median follow-up was 2.32 years (IQR = 1.8-3.1). During follow-up, 110 cardiovascular events (including 43 fatal cases) were determined. Additionally, 74 subjects were hospitalized repetitively due to worsening CHF and also 16 subjects were readmitted in the hospital due to other cardiovascular reasons. In the univariate logistic regression analysis, the main factors independently related with cumulative endpoints were creatinine, fasting glucose, HbA1c, total cholesterol, uric acid, various types of EPMs, NT-pro-BNP, hs-CRP, NYHA class, decreased left ventricular ejection fraction (LVEF) less 45%, and type 2 diabetes mellitus. In multivariate model NYHA class, decreased LVEF (less 45%), NT-pro-BNP, hs-CRP, CD144 +/CD31 +/annexin V + EMPs, and CD31 +/annexin V + EMPs remained statistically significant for cumulative endpoint. Adding of CD144 +/CD31 +/annexin V + EMCs and CD31 +/annexin V + EMCs to the standard ABC model may improve the relative IDI for cumulative endpoint by 11.4% and 10.5% respectively.
Apoptotic phenotype of circulating microparticles may relate 3-year combined clinical outcomes in CHF patients. The study aim was to evaluate whether circulating microparticles with apoptotic or non-apoptotic phenotypes are useful for risk assessment of 3-year cumulative fatal and non-fatal cardiovascular events in CHF patients.AIMThe study aim was to evaluate whether circulating microparticles with apoptotic or non-apoptotic phenotypes are useful for risk assessment of 3-year cumulative fatal and non-fatal cardiovascular events in CHF patients.The incidence of fatal and non-fatal cardiovascular events, as well as the frequency of occurrence of death from any cause in a cohort of 388 patients with CHF during 3 years of observation was studied prospectively. Circulating levels of NT-pro brain natriuretic peptide (NT-pro-BNP), high-sensitivity C-reactive protein (hs-CRP), and endothelial apoptotic microparticles (EMPs) were measured at baseline.METHODSThe incidence of fatal and non-fatal cardiovascular events, as well as the frequency of occurrence of death from any cause in a cohort of 388 patients with CHF during 3 years of observation was studied prospectively. Circulating levels of NT-pro brain natriuretic peptide (NT-pro-BNP), high-sensitivity C-reactive protein (hs-CRP), and endothelial apoptotic microparticles (EMPs) were measured at baseline.Median follow-up was 2.32 years (IQR = 1.8-3.1). During follow-up, 110 cardiovascular events (including 43 fatal cases) were determined. Additionally, 74 subjects were hospitalized repetitively due to worsening CHF and also 16 subjects were readmitted in the hospital due to other cardiovascular reasons. In the univariate logistic regression analysis, the main factors independently related with cumulative endpoints were creatinine, fasting glucose, HbA1c, total cholesterol, uric acid, various types of EPMs, NT-pro-BNP, hs-CRP, NYHA class, decreased left ventricular ejection fraction (LVEF) less 45%, and type 2 diabetes mellitus. In multivariate model NYHA class, decreased LVEF (less 45%), NT-pro-BNP, hs-CRP, CD144 +/CD31 +/annexin V + EMPs, and CD31 +/annexin V + EMPs remained statistically significant for cumulative endpoint. Adding of CD144 +/CD31 +/annexin V + EMCs and CD31 +/annexin V + EMCs to the standard ABC model may improve the relative IDI for cumulative endpoint by 11.4% and 10.5% respectively.RESULTSMedian follow-up was 2.32 years (IQR = 1.8-3.1). During follow-up, 110 cardiovascular events (including 43 fatal cases) were determined. Additionally, 74 subjects were hospitalized repetitively due to worsening CHF and also 16 subjects were readmitted in the hospital due to other cardiovascular reasons. In the univariate logistic regression analysis, the main factors independently related with cumulative endpoints were creatinine, fasting glucose, HbA1c, total cholesterol, uric acid, various types of EPMs, NT-pro-BNP, hs-CRP, NYHA class, decreased left ventricular ejection fraction (LVEF) less 45%, and type 2 diabetes mellitus. In multivariate model NYHA class, decreased LVEF (less 45%), NT-pro-BNP, hs-CRP, CD144 +/CD31 +/annexin V + EMPs, and CD31 +/annexin V + EMPs remained statistically significant for cumulative endpoint. Adding of CD144 +/CD31 +/annexin V + EMCs and CD31 +/annexin V + EMCs to the standard ABC model may improve the relative IDI for cumulative endpoint by 11.4% and 10.5% respectively.Apoptotic phenotype of circulating microparticles may relate 3-year combined clinical outcomes in CHF patients.CONCLUSIONApoptotic phenotype of circulating microparticles may relate 3-year combined clinical outcomes in CHF patients. • Endothelial microparticles may interplay in vascular remodeling and reparation. • Cardiac failure associates with elevated endothelial apoptotic microparticles. • The endothelial apoptotic microparticles predict poor prognosis in cardiac failure. |
| Author | Berezin, Alexander E. Samura, Tatyana A. Kremzer, Alexander A. Berezina, Tatyana A. Martovitskaya, Yulia V. |
| AuthorAffiliation | b Clinical Pharmacology Department, State Medical University, Zaporozhye, Ukraine a Internal Medicine Department, State Medical University, 26, Mayakovsky Av., Zaporozhye UA-69035, Ukraine d Private Medical Center “Vita-Center”, Zaporozhye, Ukraine c Pathology Department, State Medical University, Zaporozhye, Ukraine |
| AuthorAffiliation_xml | – name: d Private Medical Center “Vita-Center”, Zaporozhye, Ukraine – name: c Pathology Department, State Medical University, Zaporozhye, Ukraine – name: b Clinical Pharmacology Department, State Medical University, Zaporozhye, Ukraine – name: a Internal Medicine Department, State Medical University, 26, Mayakovsky Av., Zaporozhye UA-69035, Ukraine |
| Author_xml | – sequence: 1 givenname: Alexander E. surname: Berezin fullname: Berezin, Alexander E. – sequence: 2 givenname: Alexander A. surname: Kremzer fullname: Kremzer, Alexander A. – sequence: 3 givenname: Yulia V. surname: Martovitskaya fullname: Martovitskaya, Yulia V. – sequence: 4 givenname: Tatyana A. surname: Samura fullname: Samura, Tatyana A. – sequence: 5 givenname: Tatyana A. surname: Berezina fullname: Berezina, Tatyana A. |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26672475$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9UU1r3DAQFSEl3_-gFB17WWcky_JuDoES0iYQ6CWF3oQkj2ItWsuV7JT--2jZJKQ55DQD8z6G947J_hAHJOQzg4oBk-fryhhtg684MFExVgHIPXLEORMLKVqx_2Y_JGc5rwGA8aZdteyAHHIpWy7a5oj8vu-Rjgk7byf_iDTFgDQ6an2yc9CTHx7oxtsUR50mbwNm6gc6lgMOU6Z__dRT26c4eEt7LBjqtA9zwlPyyemQ8ex5npBf36_vr24Wdz9_3F59u1tYActpUQtnBGe2c9Y4LaEBxywaaaSErpMrwBqNxiUuTa0lgkYh-aqpl52rNfC2PiGXO91xNhvsbHkr6aDG5Dc6_VNRe_X_ZfC9eoiPSkjJGtgKfH0WSPHPjHlSG58thqAHjHNWrG1ACGiFKNAvb71eTV7iLICLHaAElnNCp6yfSlZxa-2DYqC29am12tWntvUpxlSpr5DFO_KL_oe0J6beo50 |
| CitedBy_id | crossref_primary_10_1007_s00392_018_1340_1 crossref_primary_10_1016_j_ijcard_2016_10_007 crossref_primary_10_1055_s_0043_57017 crossref_primary_10_1097_SHK_0000000000001149 crossref_primary_10_1111_joim_12459 crossref_primary_10_1016_j_dsx_2015_08_001 crossref_primary_10_1002_jcp_28499 crossref_primary_10_1152_ajpheart_00035_2023 crossref_primary_10_3390_ijms222111545 crossref_primary_10_3390_ijms241411824 crossref_primary_10_1039_C9BM01007F crossref_primary_10_1016_S1773_035X_20_30201_X crossref_primary_10_3390_biomedicines8100409 crossref_primary_10_1111_joim_12460 crossref_primary_10_5812_cardiovascmed_29094 crossref_primary_10_29328_journal_hjbm_1001001 crossref_primary_10_1007_s40618_015_0273_z crossref_primary_10_1177_1849454416663659 crossref_primary_10_17352_ach_000016 crossref_primary_10_3389_fcvm_2022_939625 crossref_primary_10_1016_j_bbacli_2015_07_002 |
| Cites_doi | 10.1016/S0003-4509(07)90020-6 10.1016/j.jacc.2011.07.032 10.1016/S0894-7317(89)80014-8 10.1097/HCO.0b013e3283587c4d 10.1111/jth.12207 10.1152/ajpheart.00265.2005 10.1155/2013/734509 10.1111/jth.12554 10.1016/j.atherosclerosis.2007.07.012 10.1080/09674845.2014.11669959 10.1016/j.thromres.2008.06.006 10.1002/cyto.a.20886 10.1182/blood.V99.11.3962 10.1016/j.amjcard.2010.12.006 10.1161/HYPERTENSIONAHA.113.02382 10.1161/CIRCULATIONAHA.108.189695 10.1007/s40291-014-0113-4 10.1016/j.atherosclerosis.2013.01.028 10.3324/haematol.13547 10.1161/CIRCRESAHA.110.226456 10.7326/0003-4819-150-9-200905050-00006 10.1161/CIRCULATIONAHA.109.192667 10.1160/TH10-02-0111 10.1161/CIRCHEARTFAILURE.112.000043 10.1136/heart.89.suppl_3.iii9 10.1007/s00441-008-0710-9 10.1007/s00392-011-0337-9 10.1161/JAHA.113.000426 10.1007/s11897-014-0219-3 10.1161/CIRCRESAHA.113.300858 10.1016/S0049-3848(03)00064-1 10.1016/j.ancard.2008.02.016 10.1007/s10741-014-9439-6 10.1016/S0008-6363(03)00367-5 |
| ContentType | Journal Article |
| Copyright | 2014 The Authors 2014 |
| Copyright_xml | – notice: 2014 The Authors 2014 |
| DBID | AAYXX CITATION NPM 7X8 5PM |
| DOI | 10.1016/j.bbacli.2014.11.006 |
| DatabaseName | CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | PubMed MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 2214-6474 |
| EndPage | 24 |
| ExternalDocumentID | PMC4661507 26672475 10_1016_j_bbacli_2014_11_006 |
| Genre | Journal Article |
| GroupedDBID | 0R~ 4.4 457 53G 5VS AAEDT AAEDW AAIKJ AALRI AAXUO AAYWO AAYXX ABMAC ACGFS ACVFH ADBBV ADCNI ADEZE ADRAZ ADVLN AEUPX AEXQZ AFPUW AGHFR AIGII AITUG AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ AOIJS CITATION EBS EJD FDB GX1 HYE IXB KQ8 M48 M~E OK1 PGMZT ROL RPM SSZ NPM 7X8 5PM |
| ID | FETCH-LOGICAL-c408t-34fb421cdfcbfa6050f1ceb6b660dd690e3ebae8e8b3a6e0ae4629538df3a0273 |
| IEDL.DBID | M48 |
| ISSN | 2214-6474 |
| IngestDate | Thu Aug 21 17:37:11 EDT 2025 Fri Jul 11 06:33:58 EDT 2025 Mon Jul 21 05:43:23 EDT 2025 Tue Jul 01 03:50:20 EDT 2025 Thu Apr 24 23:08:20 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | Cardiovascular outcomes Predictive value Chronic heart failure Microparticles |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c408t-34fb421cdfcbfa6050f1ceb6b660dd690e3ebae8e8b3a6e0ae4629538df3a0273 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.1016/j.bbacli.2014.11.006 |
| PMID | 26672475 |
| PQID | 1750440744 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4661507 proquest_miscellaneous_1750440744 pubmed_primary_26672475 crossref_citationtrail_10_1016_j_bbacli_2014_11_006 crossref_primary_10_1016_j_bbacli_2014_11_006 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2015-06-01 |
| PublicationDateYYYYMMDD | 2015-06-01 |
| PublicationDate_xml | – month: 06 year: 2015 text: 2015-06-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | Netherlands |
| PublicationPlace_xml | – name: Netherlands |
| PublicationTitle | BBA clinical |
| PublicationTitleAlternate | BBA Clin |
| PublicationYear | 2015 |
| Publisher | Elsevier |
| Publisher_xml | – name: Elsevier |
| References | Berezin (10.1016/j.bbacli.2014.11.006_bb0065) 2014; 8 Pellerin (10.1016/j.bbacli.2014.11.006_bb0110) 2003; 89 Charan Reddy (10.1016/j.bbacli.2014.11.006_bb0080) 2014 Nomura (10.1016/j.bbacli.2014.11.006_bb0130) 2008; 123 Alba (10.1016/j.bbacli.2014.11.006_bb0030) 2013; 6 De Beradinis (10.1016/j.bbacli.2014.11.006_bb0050) 2012; 27 Berezin (10.1016/j.bbacli.2014.11.006_bb0195) 2014; 2 Morel (10.1016/j.bbacli.2014.11.006_bb0160) 2007; 65 Markiewicz (10.1016/j.bbacli.2014.11.006_bb0175) 2013; 2013 Pirro (10.1016/j.bbacli.2014.11.006_bb0070) 2008; 197 Maisel (10.1016/j.bbacli.2014.11.006_bb0025) 2011; 58 Boulanger (10.1016/j.bbacli.2014.11.006_bb0140) 2008; 57 Mezentsev (10.1016/j.bbacli.2014.11.006_bb0150) 2005; 289 Levey (10.1016/j.bbacli.2014.11.006_bb0115) 2009; 150 Jimenez (10.1016/j.bbacli.2014.11.006_bb0075) 2003; 109 Montoro-García (10.1016/j.bbacli.2014.11.006_bb0185) 2013; 227 Orozco (10.1016/j.bbacli.2014.11.006_bb0125) 2010; 77 Oremus (10.1016/j.bbacli.2014.11.006_bb0035) 2014; 19 Sabatier (10.1016/j.bbacli.2014.11.006_bb0155) 2002; 99 Matsuzawa (10.1016/j.bbacli.2014.11.006_bb0190) 2013; 2 Bluemke (10.1016/j.bbacli.2014.11.006_bb0100) 2008; 118 Chironi (10.1016/j.bbacli.2014.11.006_bb0180) 2009; 335 Lloyd-Jones (10.1016/j.bbacli.2014.11.006_bb0005) 2010; 121 Santulli (10.1016/j.bbacli.2014.11.006_bb0090) 2011; 107 Carrasco-Sánchez (10.1016/j.bbacli.2014.11.006_bb0040) 2014; 18 Pérez-Casal (10.1016/j.bbacli.2014.11.006_bb0145) 2009; 94 Loyer (10.1016/j.bbacli.2014.11.006_bb0165) 2014; 114 Arraud (10.1016/j.bbacli.2014.11.006_bb0060) 2014; 12 Santulli (10.1016/j.bbacli.2014.11.006_bb0095) 2014; 63 Rajendiran (10.1016/j.bbacli.2014.11.006_bb0045) 2014; 71 Tschöpe (10.1016/j.bbacli.2014.11.006_bb0020) 2014; 11 Wronska (10.1016/j.bbacli.2014.11.006_bb0085) 2014 Leroyer (10.1016/j.bbacli.2014.11.006_bb0135) 2010; 104 Lacroix (10.1016/j.bbacli.2014.11.006_bb0120) 2013 Santulli (10.1016/j.bbacli.2014.11.006_bb0010) 2013; 1 VanWijk (10.1016/j.bbacli.2014.11.006_bb0170) 2003; 59 Schiller (10.1016/j.bbacli.2014.11.006_bb0105) 1989; 2 Mause (10.1016/j.bbacli.2014.11.006_bb0055) 2010; 107 Ehrlich (10.1016/j.bbacli.2014.11.006_bb0015) 2011; 100 |
| References_xml | – volume: 65 start-page: 75 issue: 2 year: 2007 ident: 10.1016/j.bbacli.2014.11.006_bb0160 article-title: Markers of thrombotic disease: procoagulant microparticles publication-title: Ann. Pharm. Fr. doi: 10.1016/S0003-4509(07)90020-6 – year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0080 article-title: Regulatory noncoding RNAs in cardiovascular disease: shedding light on ‘dark matter’ publication-title: JCvD – volume: 58 start-page: 1890 issue: 18 year: 2011 ident: 10.1016/j.bbacli.2014.11.006_bb0025 article-title: Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research publication-title: J. Am. Coll. Cardiol. doi: 10.1016/j.jacc.2011.07.032 – volume: 2 start-page: 358 year: 1989 ident: 10.1016/j.bbacli.2014.11.006_bb0105 article-title: Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms publication-title: J. Am. Soc. Echocardiogr. doi: 10.1016/S0894-7317(89)80014-8 – volume: 27 start-page: 661 issue: 6 year: 2012 ident: 10.1016/j.bbacli.2014.11.006_bb0050 article-title: Use of biomarkers to guide outpatient therapy of heart failure publication-title: Curr. Opin. Cardiol. doi: 10.1097/HCO.0b013e3283587c4d – year: 2013 ident: 10.1016/j.bbacli.2014.11.006_bb0120 article-title: The ISTH SSC Workshop. Standardization of pre-analytical variables in plasma microparticle determination: results of the International Society on Thrombosis and Haemostasis SSC Collaborative workshop publication-title: J. Thromb. Haemost. doi: 10.1111/jth.12207 – volume: 289 start-page: H1106 issue: 3 year: 2005 ident: 10.1016/j.bbacli.2014.11.006_bb0150 article-title: Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress publication-title: Am. J. Physiol. Heart Circ. Physiol. doi: 10.1152/ajpheart.00265.2005 – volume: 2013 start-page: 734509 year: 2013 ident: 10.1016/j.bbacli.2014.11.006_bb0175 article-title: Impact of endothelial microparticles on coagulation, inflammation, and angiogenesis in age-related vascular diseases publication-title: J. Aging Res. doi: 10.1155/2013/734509 – volume: 2 start-page: 50 issue: 2 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0195 article-title: Apoptotic microparticles to progenitor mononuclear cells ratio in heart failure: relevance of clinical status and outcomes publication-title: JCvD – volume: 12 start-page: 614 issue: 5 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0060 article-title: Extracellular vesicles from blood plasma: determination of their morphology, size, phenotype and concentration publication-title: J. Thromb. Haemost. doi: 10.1111/jth.12554 – volume: 197 start-page: 757 issue: 2 year: 2008 ident: 10.1016/j.bbacli.2014.11.006_bb0070 article-title: Microparticles derived from endothelial progenitor cells in patients at different cardiovascular risk publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2007.07.012 – year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0085 article-title: Application of microRNAs in diagnosis and treatment of cardiovascular disease publication-title: Acta Physiol. – volume: 71 start-page: 29 issue: 1 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0045 article-title: Elevated levels of serum sialic acid and high-sensitivity C-reactive protein: markers of systemic inflammation in patients with chronic heart failure publication-title: Br. J. Biomed. Sci. doi: 10.1080/09674845.2014.11669959 – volume: 123 start-page: 8 year: 2008 ident: 10.1016/j.bbacli.2014.11.006_bb0130 article-title: Function and role of microparticles in various clinical settings publication-title: Thromb. Res. doi: 10.1016/j.thromres.2008.06.006 – volume: 77 start-page: 502 issue: 6 year: 2010 ident: 10.1016/j.bbacli.2014.11.006_bb0125 article-title: Flow cytometric analysis of circulating microparticles in plasma publication-title: Cytometry A doi: 10.1002/cyto.a.20886 – volume: 99 start-page: 3962 year: 2002 ident: 10.1016/j.bbacli.2014.11.006_bb0155 article-title: Interaction of endothelial microparticles with monocytic cells in vitro induces tissue factor-dependent procoagulant activity publication-title: Blood doi: 10.1182/blood.V99.11.3962 – volume: 107 start-page: 1125 year: 2011 ident: 10.1016/j.bbacli.2014.11.006_bb0090 article-title: G protein-coupled receptor kinase 2 in patients with acute myocardial infarction publication-title: Am. J. Cardiol. doi: 10.1016/j.amjcard.2010.12.006 – volume: 63 start-page: 215 issue: 2 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0095 article-title: Adrenal signaling in heart failure: something more than a distant ship's smoke on the horizon publication-title: Hypertension doi: 10.1161/HYPERTENSIONAHA.113.02382 – volume: 118 start-page: 586 year: 2008 ident: 10.1016/j.bbacli.2014.11.006_bb0100 publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.108.189695 – volume: 18 start-page: 599 issue: 6 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0040 article-title: Review of the prognostic value of galectin-3 in heart failure focusing on clinical utility of repeated testing publication-title: Mol. Diagn. Ther. doi: 10.1007/s40291-014-0113-4 – volume: 227 start-page: 313 issue: 2 year: 2013 ident: 10.1016/j.bbacli.2014.11.006_bb0185 article-title: Small-size circulating microparticles in acute coronary syndromes: relevance to fibrinolytic status, reparative markers and outcomes publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2013.01.028 – volume: 1 start-page: 1 issue: 1 year: 2013 ident: 10.1016/j.bbacli.2014.11.006_bb0010 article-title: Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts publication-title: JCvD – volume: 94 start-page: 387 year: 2009 ident: 10.1016/j.bbacli.2014.11.006_bb0145 article-title: Microparticle-associated endothelial protein C receptor and the induction of cytoprotective and anti-inflammatory effects publication-title: Haematologica doi: 10.3324/haematol.13547 – volume: 107 start-page: 1047 year: 2010 ident: 10.1016/j.bbacli.2014.11.006_bb0055 article-title: Microparticles: protagonists of a novel communication network for intercellular information exchange publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.110.226456 – volume: 150 start-page: 604 issue: 9 year: 2009 ident: 10.1016/j.bbacli.2014.11.006_bb0115 article-title: A new equation to estimate glomerular filtration rate publication-title: Ann. Intern. Med. doi: 10.7326/0003-4819-150-9-200905050-00006 – volume: 121 start-page: e46 issue: 7 year: 2010 ident: 10.1016/j.bbacli.2014.11.006_bb0005 article-title: Heart disease and stroke statistics—2010 update: a report from the American Heart Association publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.109.192667 – volume: 104 start-page: 456 year: 2010 ident: 10.1016/j.bbacli.2014.11.006_bb0135 article-title: Endothelial-derived microparticles: biological conveyors at the crossroad of inflammation, thrombosis and angiogenesis publication-title: Thromb. Haemost. doi: 10.1160/TH10-02-0111 – volume: 6 start-page: 881 issue: 5 year: 2013 ident: 10.1016/j.bbacli.2014.11.006_bb0030 article-title: Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review publication-title: Circ. Heart Fail. doi: 10.1161/CIRCHEARTFAILURE.112.000043 – volume: 89 start-page: iii9 issue: 90003 year: 2003 ident: 10.1016/j.bbacli.2014.11.006_bb0110 article-title: Tissue Doppler, strain, and strain rate echocardiography for the assessment of left and right systolic ventricular function publication-title: Heart doi: 10.1136/heart.89.suppl_3.iii9 – volume: 335 start-page: 143 year: 2009 ident: 10.1016/j.bbacli.2014.11.006_bb0180 article-title: Endothelial microparticles in diseases publication-title: Cell Tissue Res. doi: 10.1007/s00441-008-0710-9 – volume: 100 start-page: 1029 issue: 11 year: 2011 ident: 10.1016/j.bbacli.2014.11.006_bb0015 article-title: Biomarkers of structural remodelling and endothelial dysfunction for prediction of cardiovascular events or death in patients with atrial fibrillation publication-title: Clin. Res. Cardiol. doi: 10.1007/s00392-011-0337-9 – volume: 2 start-page: e000426 issue: 6 year: 2013 ident: 10.1016/j.bbacli.2014.11.006_bb0190 article-title: Peripheral endothelial function and cardiovascular events in high-risk patients publication-title: J. Am. Heart Assoc. doi: 10.1161/JAHA.113.000426 – volume: 11 start-page: 436 issue: 4 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0020 article-title: New insights in (inter)cellular mechanisms by heart failure with preserved ejection fraction publication-title: Curr. Heart Fail. Rep. doi: 10.1007/s11897-014-0219-3 – volume: 114 start-page: 345 issue: 2 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0165 article-title: Microvesicles as cell–cell messengers in cardiovascular diseases publication-title: Circ. Res. doi: 10.1161/CIRCRESAHA.113.300858 – volume: 109 start-page: 175 year: 2003 ident: 10.1016/j.bbacli.2014.11.006_bb0075 article-title: Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis publication-title: Thromb. Res. doi: 10.1016/S0049-3848(03)00064-1 – volume: 57 start-page: 149 year: 2008 ident: 10.1016/j.bbacli.2014.11.006_bb0140 article-title: Circulating endothelial microparticles: a new marker of vascular injury publication-title: Ann. Cardiol. Angeiol. (Paris) doi: 10.1016/j.ancard.2008.02.016 – volume: 19 start-page: 471 issue: 4 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0035 article-title: BNP and NT-proBNP as prognostic markers in persons with chronic stable heart failure publication-title: Heart Fail. Rev. doi: 10.1007/s10741-014-9439-6 – volume: 8 start-page: 116 issue: 3 year: 2014 ident: 10.1016/j.bbacli.2014.11.006_bb0065 article-title: Circulating endothelial-derived apoptotic microparticles in the patients with ischemic symptomatic chronic heart failure: relevance of pro-inflammatory activation and outcomes publication-title: Int. Cardiovasc. Res. J. – volume: 59 start-page: 277 issue: 2 year: 2003 ident: 10.1016/j.bbacli.2014.11.006_bb0170 article-title: Microparticles in cardiovascular diseases publication-title: Cardiovasc. Res. doi: 10.1016/S0008-6363(03)00367-5 |
| SSID | ssj0001257971 |
| Score | 2.0811975 |
| Snippet | The study aim was to evaluate whether circulating microparticles with apoptotic or non-apoptotic phenotypes are useful for risk assessment of 3-year cumulative... • Endothelial microparticles may interplay in vascular remodeling and reparation. • Cardiac failure associates with elevated endothelial apoptotic... |
| SourceID | pubmedcentral proquest pubmed crossref |
| SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | 18 |
| SubjectTerms | Regular |
| Title | The predictive role of circulating microparticles in patients with chronic heart failure |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/26672475 https://www.proquest.com/docview/1750440744 https://pubmed.ncbi.nlm.nih.gov/PMC4661507 |
| Volume | 3 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3dS9xAEB-sUuiLWG1r1MoKfY3kY7KbeyhFpYcK-tSDvIX9bFPO3Hkf4P337lyS07MtBZ-zG8LM7M7M7i-_H8AX4rTJ0PBQJVkeos5UmDvHw9QYlwvMlVhSCt3c8ssBXhdZsQGdZmtrwOlfWzvSkxpMhqcP94tvfsF_fcJqKSX1sCKgFp4SJydxcG_53CRI0-CmLfibU5dM9ETc_UP3j8nEEMy5SJDQh8_T1R816Eso5bPc1N-B7baoZGdNFLyHDVvvwttGZnKxB4WPBTae0JUMbW6MEIVs5JiuJnqp3lX_ZHcEzBt3MDlW1axlXJ0yOqpluiHRZSSAPWNOVgRn_wCD_vcfF5dhq6gQaozyWZiiU5jE2jitnPSdTORibRVXnEfG-EbZplZJm9tcpZLbSFrkSc_vicalkphvPsJmPartPrBe6pTJELUSEiOMc4OxTRxK6RKJaRJA2hmu1C3dOKleDMsOV_a7bCxfkuV9J1J6ywcQrmaNG7qN_4w_6XxS-nVBlx2ytqP5tIyJt953q4gBfGp8tHpj59wAxJr3VgOIc3v9SV39WnJvIycGfXHw6pmH8M5_f9agzY5gczaZ28--rpmpY3hzVZwfLwP2EbaS-8E |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+predictive+role+of+circulating+microparticles+in+patients+with+chronic+heart+failure&rft.jtitle=BBA+clinical&rft.au=Berezin%2C+Alexander+E.&rft.au=Kremzer%2C+Alexander+A.&rft.au=Martovitskaya%2C+Yulia+V.&rft.au=Samura%2C+Tatyana+A.&rft.date=2015-06-01&rft.pub=Elsevier&rft.eissn=2214-6474&rft.volume=3&rft.spage=18&rft.epage=24&rft_id=info:doi/10.1016%2Fj.bbacli.2014.11.006&rft_id=info%3Apmid%2F26672475&rft.externalDocID=PMC4661507 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-6474&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-6474&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-6474&client=summon |